Hengbin Cao
Dados Biográficos
| ID | 9995536 |
|---|---|
| NOME | Hengbin Cao |
| PRENOMES | Hengbin |
| SOBRENOME | Cao |
| ASSINATURA | CAO H |
| AFILIAÇÕES | Huzhou Central Hospital |
| VERIFICADO | Não |
| TOTAL DE OBRAS | 1 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 1 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2022 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2022 |
| ÍNDICE H | 0 |
Expert consensus statement on therapeutic drug monitoring and individualization of linezolid
Linezolid is an oxazolidinone antibacterial drug, and its therapeutic drug monitoring and individualized treatment have been challenged since its approval. With the in-depth clinical research of linezolid, we have changed our attitude toward its therapeutic drug monitoring and our view of individualized treatment. On the basis of summarizing the existing clinical studies, and based on the practical experience of each expert in their respective pr…
Sem obras proeminentes nesta página.
Expert consensus statement on therapeutic drug monitoring and individualization of linezolid
Linezolid is an oxazolidinone antibacterial drug, and its therapeutic drug monitoring and individualized treatment have been challenged since its approval. With the in-depth clinical research of linezolid, we have changed our attitude toward its therapeutic drug monitoring and our view of individualized treatment. On the basis of summarizing the existing clinical studies, and based on the practical experience of each expert in their respective pr…
Antibiotics Pharmacokinetics and Efficacy (1 obras) · Antimicrobial Resistance in Staphylococcus (1 obras) · Bacterial Identification and Susceptibility Testing (1 obras) · Clinical trial (1 obras) · Compassionate Use (1 obras) · Drug (1 obras) · Intensive care medicine (1 obras) · Internal Medicine (1 obras) · Linezolid (1 obras) · Medicine (1 obras)